logo
Can I trust my sunscreen? Choice test results have created uncertainty over SPF claims and lab testing process

Can I trust my sunscreen? Choice test results have created uncertainty over SPF claims and lab testing process

The Guardian12-07-2025
Sunscreen has been in the spotlight this winter, after testing by the consumer advocacy organisation Choice found 16 of 20 brands failed to provide the level of skin protection advertised on their bottles.
With Australia having one of the highest rates of skin cancer in the world, the Choice report left many worried and wondering: can I trust my sunscreen to protect me?
Even four Cancer Council branded sunscreens were flagged in the report: its Ultra Sunscreen SPF 50+ was found by Choice to have a sun protection factor of 24. The worst result, though, belonged to Ultra Violette's Lean Screen SPF 50+, which Choice's testing found had an SPF of just 4.
While some brands have fiercely disputed the findings, the investigation has prompted debate over the reliability of sunscreen testing, as well as questions over the way these products are regulated.
What's going on?
Australians love spending time in the sun and sun safety is instilled in people from a young age.
So the Choice investigation, with its results published in June, created a storm. Choice tested 20 popular SPF 50 or 50+ sunscreens from a range of retailers and prices in a specialised, accredited laboratory and found 16 of them did not meet their SPF claims.
No surprise, the Choice results have been contentious.
Choice has said it handed over its findings to the companies before they were released publicly. Some have produced test certificates showing that their product met the claimed SPF using the same testing method that Choice used.
When contacted by Guardian Australia, the brands stood firmly by their SPF claims and said they test their products in accordance with the regulations. The Cancer Council said it stood by its previous results but, out of an abundance of caution, has submitted their four products that Choice reviewed for additional testing.
Sign up for Guardian Australia's breaking news email
Ultra Violette, the sunscreen brand that had by far the worst-performing product according to Choice's testing, has fiercely disputed the findings. The Ultra Violette Lean Screen SPF 50 plus Mattifying Zinc Skin Screen, a higher-end product that retails for upwards of $50, returned a result of just 4 in Choice's test. A second test returned a result of 5, Choice said.
Ultra Violette has disputed Choice's findings very strongly and very publicly. It has taken the step of speaking directly to consumers via social media. One of the brand's co-founders, Ava Chandler-Matthews, posted a video on Instagram in which she strongly disputed Choice's methodology. In response, Choice has defended the rigour of its testing.
The SPF or sun protection factor rating of a sunscreen measures how well it protects the skin from sunburn by indicating how much ultraviolet radiation can still penetrate the skin through the product when applied properly. For example, SPF 30 is estimated to filter 96.7% of UVB radiation, whereas SPF 50 is estimated to filter 98%.
Dr DJ Kim, a senior lecturer at the University of New South Wales' school of chemistry, says the difference between SPF 30 and SPF 50 is actually 'very marginal'.
Kim says SPF ratings are given by timing how long it takes skin to burn with and without the sunscreen.
'Let's say that you took 300 seconds for your skin to burn with sunscreen, and then if … it took 10 seconds to burn without the sunscreen, then 300 divided by 10, that becomes SPF 30,' he says. 'So, it's not the most scientific method to measure the SPF factor, honestly.'
SPF claims in Australia are regulated by the Therapeutic Goods Administration (TGA).
Sunscreen brands must get approval from the TGA to sell their products to Australian consumers. To do this, they undertake SPF testing in accordance with the Australian/New Zealand standard in an approved laboratory.
The accepted method is to test sunscreen on human skin. The methodology involves putting the sunscreen on 10 volunteers who are exposed to artificial solar UV radiation. This is the method Choice says it used, working with an accredited laboratory that specialises in sunscreen testing.
Sunscreen brands submit their results to the TGA for approval to 'self-certify' that they have tested their SPF claims and that they stack up. The TGA does not usually do its own testing.
Dr Michelle Wong, a cosmetic chemist, says she doubts the TGA would have the resources to do all of the testing itself.
'And so, in terms of the regulations, most of the time, in this sort of situation where it's a public body, there is always going to be some level of an honour system,' she says.
There are potential inconsistencies in sunscreen testing. SPF effectiveness is measured by essentially getting people to put sunscreens in patches on their skin and measuring how 'red' they get over time.
A TGA spokesperson says it is a known issue that there is variability in SPF testing results across laboratories because testing on humans can be highly subjective and the response to a test can differ dramatically from one individual to another.
'While progress is being made internationally toward in-vitro sunscreen testing (for example, not on human subjects), which will improve consistency of results, these methods are not yet in place,' they said.
Wong, who is known for her work on social media and her blog Lab Muffin, says in-vitro testing would be easier for the TGA to run in-house, which would limit the variability of the results and stop the potential for fraud at labs seeking to make a profit.
She also suggests having a limited number of designated labs that are accepted by the TGA for sunscreen testing.
Wong says although sunscreen is complicated and there are 'technicalities' in the testing and regulation process, the most common problem is 'user error' in that people aren't applying enough product often enough.
'Sunscreens, in general, they work very well, and they are very effective at protecting your skin against sun exposure,' she says, noting that a sunscreen with an SPF of, say, 24 still offers very good protection.
Not long after Choice published its findings, sunscreen was back in the news for different reasons.
Last week, the TGA said it would begin consultation on additional controls for some sunscreen ingredients, including the controversial oxybenzone.
The medicines regulator says it has conducted a review of sunscreen ingredients used in Australia and is recommending additional safeguards for three chemical compounds.
The review proposes that some sunscreen products containing homosalate, oxybenzone and benzophenone be reformulated to ensure sunscreens meet what the TGA considers 'the highest standards of safety for prolonged and frequent use'.
Homosalate and oxybenzone are active ingredients in sunscreen, while benzophenone arises from another ingredient called octocrylene, either as an impurity during the manufacturing process or from degradation as the product ages.
The TGA has begun a consultation process to help determine the level in sunscreens at which these ingredients remain suitable for use.
A week before that, the Australian Competition and Consumer Commission launched legal action against the maker of two popular sunscreens over allegations it had misled consumers by falsely claiming its products are 'reef-friendly'.
The consumerregulator alleges Edgewell Personal Care engaged in greenwashing. While these sunscreens do not contain oxybenzone or octinoxate, another chemical linked to coral damage, the ACCC alleges that they contain other ingredients that risk causing harm to coral and marine life. Edgewell is contesting the proceedings.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

I took a very common supplement because it was supposed to help me... my world has been turned upside down and I know I'm not alone
I took a very common supplement because it was supposed to help me... my world has been turned upside down and I know I'm not alone

Daily Mail​

time11 hours ago

  • Daily Mail​

I took a very common supplement because it was supposed to help me... my world has been turned upside down and I know I'm not alone

A young Australian has claimed a B6 supplement has left him with pain and cognitive issues, as a law firm launches a class action investigation against Blackmores. Melbourne man Dominic Noonan-O'Keeffe, 33, began taking two supplements partly on the advice of health podcasters in May 2023. Over the course of several months of using the company's Blackmores Super Magnesium+ and Ashwagandha+, he developed a range of symptoms associated with overexposure to vitamin B6. Vitamin B6 is a nutrient naturally found in meats and plants, but has been added to off-the-shelf supplement ranges for its properties aiding metabolism. Overconsumption of vitamin B6 can be toxic, though there is no consensus on the threshold for safe usage. Mr Noonan-O'Keeffe's symptoms began as fatigue, nerve pain, migraines, and visual disturbances. Nine months later, his stepsister asked if he was taking B6 supplements, as a colleague of hers had recently suffered B6 toxicity. 'It was a lightbulb moment,' Mr Noonan-O'Keeffe told the Sydney Morning Herald. 'I stopped all of my supplements straight away, got a blood test, and within a week, I had a diagnosis of B6 toxicity.' He later discovered the Magnesium+ he had been taking contained approximately 29 times the recommended daily intake of vitamin B6. The Frankston man still suffers numbness in his fingers, nerve pain in his neck, and reduced cognitive ability. 'I'm hoping I'm at the tail end of a big flare-up, and this is the start of recovery, even though we know the recovery prospects are pretty unknown,' Mr Noonan-O'Keeffe said. Injury law firm Polaris Lawyers has been pursuing a class action investigation against the wellness giant since May. They are acting on behalf of anyone who has suffered injuries after taking their supplements. Polaris principal Nick Mann said more than 300 people had enquired about joining the suit. Their respondents claimed to have suffered after taking B6 supplements, exclusively and in combination with other supplements. Elli Carew, 64, said she had been inadvertently taking the vitamin through other supplements for several years, with B6 toxicity now interfering with the treatment of her Parkinson's disease. Penny Thompson, 61, said her B6 toxicity first presented as numbness in her hands and feet, before she suffered from paralysed vocal cords. The vocal injury, affecting her ability to eat and speak, cost her her role as a TAFE teacher, before she developed other injuries like headaches, gut pain, and numbness. Mr Mann said the reports were 'alarming'. 'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far above the recommended daily intake,' he said. 'Consumers of supplements have a right to be confident that the product they purchase will be safe for their use. 'The fact that potentially harmful supplements have been approved for sale by the regulator does not alter the legal obligations of manufacturers to ensure that the products are safe for consumers.' In a decision posted in June, the TGA announced it would consider ordering supplements containing more than 50mg of vitamin B6 to be stored behind pharmacy counters. Such a change would not come into effect until February 2027. A Blackmores spokesman told Daily Mail Australia the company was committed to the 'highest standards of product quality and consumer safety'. 'All our products, including those containing vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' he said. 'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements. 'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'

How the cost-of-living crisis is making younger Aussies ditch expensive alcohol for a deadly drug
How the cost-of-living crisis is making younger Aussies ditch expensive alcohol for a deadly drug

Daily Mail​

time20 hours ago

  • Daily Mail​

How the cost-of-living crisis is making younger Aussies ditch expensive alcohol for a deadly drug

Overdoses related to the deadly 'don't wake up' drug have skyrocketed among Australians in recent years as some fear financial pressures may be pushing young people towards hard substances. Gamma hydroxybutyrate, better known as GHB, is being used by an increasingly large number of younger Aussies. Many believe its low cost, accessibility, and mind-altering effects are making it an increasingly popular alternative to alcohol. The drug has attracted global attention due to the notoriously small margin of error between the amount used for an average recreational dosage and an overdose. The effects - relaxation, sociability, euphoria and an increased sex drive - can be felt within 15 minutes. But, even a slight overdose of the drug can prove fatal. The number of GHB-related ambulance callouts has surged across Australia in recent years according to new research from Monash University and Turning Point. Victoria is the national capital for GHB-related ambulance attendances, with 65.8 attendances per 100,000 people in 2023. It represented a 67 per cent increase from the year prior, following a 147 per cen t increase across the state between 2012 and 2019. Attendances also spiked in Tasmania, increasing by 346 per cent between 2022 and 2023. Reformed ice dealer Braiden Tonks recently told Daily Mail Australia GHB was on the rise nationwide for its sought-after side-effects. 'It just slows your heart right down, puts you into a completely relaxed state where your heart will just slowly beat and just slowly just stop, that's how you die from it,' he said. 'It's not like an instant bang of being stabbed, I'm dead. It's just slow, just like, go to sleep, don't wake up.' Young people are more likely both to abuse the drug and to require emergency help following GHB use. Affordability aside, some believe financial pressures are contributing to an appetite for harder substances. Canberra emergency consulant Dr David Caldicott told ABC News its promise of 'escape' from reality was more influential than its afforability. 'I think young people are looking for an escape from what really does not appear to be a very attractive future for them,' he said. 'I think that's probably a considerably more important element than the cost.' Uncover Mental Health Counselling founder and psychotherapist Kristie Tse said financial pressures were engendering a 'need for relief'. 'One of the biggest drivers is the desire to escape or cope with stress, which has been exacerbated by rising financial pressures and uncertainty about the future,' she told NewsWire. 'The cost of living plays into this, as financial strain can lead to heightened anxiety and a need for relief, which some may seek through substance use.' One Touch finance founder Maria Rosey told NewsWire cost-of-living pressures can create circumstances where substance use is seen as more acceptable. 'As money stress becomes more common, so does the acceptance of substances as coping mechanisms,' she said. 'The increase in GHB use during the money crisis shows us that substance use problems can't be solved by focusing only on the substances themselves. 'We need to address the conditions that make people turn to substances in the first place.'

Why Starmer's nuclear power push raises cancer fears
Why Starmer's nuclear power push raises cancer fears

Telegraph

timea day ago

  • Telegraph

Why Starmer's nuclear power push raises cancer fears

In 1942, the Mallinckrodt Chemical Works, which was processing uranium for the first atomic bomb, ran out of space for its radioactive waste and moved it to an open air storage site near Coldwater Creek, north of St Louis. More than 80 years later, Harvard University has shown that communities living near the Creek, a tributary of the Missouri River, had an elevated risk of cancer. The findings, released this week, showed a dose-response effect, with those living nearest to the water having a far higher chance of developing most cancers than those living farther away. Researchers say it highlights the dangers from exposure to even small amounts of radiation over time, and warn governments must be cautious when building new nuclear sites near towns and villages. 'Our research indicates that the communities around North St. Louis appear to have had excess cancer from exposure to the contaminated Coldwater Creek,' said Professor Marc Weisskopf, an expert in environmental epidemiology and physiology. 'These findings may have broader implications—as countries think about increasing nuclear power and developing more nuclear weapons, the waste from these entities could have huge impacts on people's health, even at these lower levels of exposure.' 'Golden age of clean energy' The warning comes at a time when the government is seeking to increase nuclear power in Britain, announcing £14.2 billion for a new nuclear plant at Sizewell in Suffolk, and £2.5 billion for a small nuclear reactor programme. Ed Miliband, the energy secretary said nuclear power was crucial 'to deliver a golden age of clean energy abundance.' But for decades there have been fears that the radiation from power stations can cause cancer, with some evidence showing clusters of leukaemia and non-Hodgkin lymphoma near Sellafield in Cumbria, and Dounreay, on the north coast of Scotland. Nuclear plants have also been linked to increased cancer incidence in the US and Germany. The public was first alerted to the possibility that nuclear plants could be causing cancer when an ITV documentary in 1983 revealed a high number of childhood leukaemia cases between 1955 and 1983 in the village of Seascale, near Sellafield. While less than one case should have been expected in such a small community, researchers found seven youngsters suffering from the condition. Residents feared that radioactive discharges may be to blame and the Committee on Medical Aspects of Radiation in the Environment (Comare) was set up to investigate. Investigations by Comare did show that rates of two types of childhood leukaemia and Non-Hodgkin Lymphoma, were significantly higher than expected, and researchers found a similar cluster at Thurso near Dounreay. However researchers did not find raised rates in other villages near Sellafield and Dounreay leading them to think that something else was causing the rise, potentially local infections which are known to trigger cancer in some cases. The investigators theorised that an influx of workers moving to Seascale and Thurso to work in the nuclear industry may have exposed local residents to new infections, sparking a rise in childhood cancer rates. Viruses such as Epstein-Barr are thought to be linked to cancers such as non-Hodgkin's lymphoma. This week, Imperial College and the University of Bristol published new research showing no increased risk for youngsters living within around 15 miles of a British nuclear plant. Researchers analysed cancer incidence data for nearly 50,000 cases of childhood leukaemia, non-Hodgkin's lymphoma, central nervous system tumours, and other solid tumours in children aged 0 to 14 years between 1995 and 2016. They cross-referenced it against data for communities living near nuclear plants, including Sellafield and Dounreay but found no increase in cases compared to the national average. Dr Bethan Davies, from Imperial's School of Public Health, said: 'For many years there have been public concerns about the potential health impacts of living near nuclear installations. 'Our analysis suggests that children living near these sites today are not at increased risk. 'As the UK government announces a multibillion-pound investment for new nuclear energy infrastructure, our findings should provide reassurance that the historical clusters of childhood cancers reported near sites such as Sellafield and Dounreay are no longer evident.' But the Coldwater Creek case shows the danger that can come from supposedly safe radioactive storage facilities. In that case, wind, rain and flooding are thought to have allowed radioactive material to leach into groundwater. A clean up operation is ongoing which is not expected to be complete until 2038 and the US government has just expanded the Radiation Exposure Compensation Act (RECA), so that those affected can claim medical expenses. The UK Health Alliance on Climate Change also warns that there are health risks associated with living near and working in a nuclear plant, citing German research showing young children living within a few miles of a site are particularly vulnerable. 'Any proposed development of nuclear power as a source of energy must take into account potential risks to human health,' the alliance said in a position statement last month. Imperial College warned it was important to continue to monitor health data at nuclear plants, but said its latest findings should reassure communities living close to reactors. Professor Mireille Toledano, Mohn Chair in Population Child Health in Imperial's School of Public Health, said: 'These findings are both timely and important. As the UK and other countries expand their nuclear energy capacity, it's vital that public health remains a central consideration. 'It's reassuring that our study found that the historic case clusters have resolved, but it remains important we continue to monitor public health data around such sites across the UK for any emerging trends of concern.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store